Characterization of solid-state forms of celecoxib.


This study deals with the generation and characterization of various solid-state forms of celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor. The drug was subjected to polymorphic screen using different solvents to explore the possibility of existence of different solid forms. N,N-Dimethyl acetamide (DMA) and N,N-dimethyl formamide (DMF) yielded solvates in 1:1 stoichiometric ratio. Quench cooling of the melt resulted in amorphous form of the drug. All these solid-state forms were characterized by thermoanalytical (DSC, TGA, HSM), crystallographic (XRD), microscopic (polarized, SEM), spectroscopic (FTIR), and elemental analysis techniques. Solubility and van't Hoff studies were carried out for their thermodynamic interpretation. Influence of morphology of different solid-state forms on flow behavior was also investigated. Molecular modeling studies were used to elucidate the interaction between solute and solvent molecules in the solvate.

12 Figures and Tables

Showing 1-10 of 18 references

Celecoxib, a COX-II inhibitor. Acta Cryst. C55

  • R V Dev, K S Rekha, K Vyas, S B Mohanti, P R Kumar, G O Reddy
  • 1999
Highly Influential
1 Excerpt

MOMEC force field parameters

  • T Halgren
  • 1990
Highly Influential
2 Excerpts

50 top selling drugs ranked by worldwide sales for 2000, Patent scan—a monthly proactive patents bulletin for pharmaceutical industry

  • Anonymous
  • 2001
1 Excerpt

Polymorphic crystalline forms of celecoxib

  • F Leonard, M Patricia
  • 2001
2 Excerpts

Alteration of the solid state of the drug substance: polymorphs, solvates, and amorphous forms Water Insoluble Drug Formulation

  • M Jozwiakowski
  • 2000
1 Excerpt
Showing 1-10 of 19 extracted citations
Citations per Year

1,146 Citations

Semantic Scholar estimates that this publication has received between 258 and 3,132 citations based on the available data.

See our FAQ for additional information.